Showing 1 - 5 results of 5 for search 'T. G. Reda', query time: 0.02s Refine Results
  1. 1
    P659: IBRUTINIB IN OVER-EIGHTIES PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTICENTER ITALIAN COHORT

    P659: IBRUTINIB IN OVER-EIGHTIES PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTICENTER ITALIAN COHORT by G. Reda, V. Mattiello, A. M. Frustaci, A. Visentin, F. R. Mauro, I. Innocenti, M. Gentile, D. Giannarelli, A. Noto, R. Cassin, L. Laurenti, A. Tedeschi

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY.

    P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY. by G. Garcia-Manero, S. Bart, J. K. McCloskey, P. Fenaux, D. Selleslag, G. Reda, D. Valcárcel, V. Santini, J. Mayer, B. Xicoy, H. Yamaguchi, M. Lübbert, Y. Miyazaki, H. Keer, Y. Hao, M. Azab, H. Döhner

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P564: FINAL RESULTS OF THE QOLESS AZA-AMLE RANDOMIZED TRIAL TO EVALUATE THE EFFICACY OF 5-AZA FOR POST-REMISSION THERAPY OF ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS

    P564: FINAL RESULTS OF THE QOLESS AZA-AMLE RANDOMIZED TRIAL TO EVALUATE THE EFFICACY OF 5-AZA FOR POST-REMISSION THERAPY OF ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS by E. N. Oliva, P. Salutari, F. Di Raimondo, G. Reda, D. Capelli, G. Iannì, G. Tripepi, C. Alati, C. Mammì, M. G. D’Errigo, P. Niscola, C. Selleri, P. Musto, E. Vigna, A. Volpe, N. Cascavilla, M. C. Cannatà, D. Mannina, A. Candoni

    Published 2022-06-01
    Get full text
    Article
  4. 4
    P660: SEROLOGIC RESPONSE TO THE SECOND AND THIRD DOSE OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PROSPECTIVE, CENTRALIZED, MULTICENTER STUDY.

    P660: SEROLOGIC RESPONSE TO THE SECOND AND THIRD DOSE OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PROSPECTIVE, CENTRALIZED, MULTICENTER ST... by F. R. Mauro, D. Giannarelli, C. Galluzzo, A. Visentin, A. M. Frustaci, P. Sportoletti, C. Vitale, G. Reda, M. Gentile, L. Levato, R. Murru, D. Armiento, C. Ielo, R. Maglione, E. Crisanti, A. Cipiciani, V. Mattiello, V. Gianfelici, L. Barabino, R. Amici, M. Coscia, A. Tedeschi, L. Trentin, S. Baroncelli

    Published 2022-06-01
    Get full text
    Article
  5. 5
    P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE

    P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE by R. Bomben, F. M. Rossi, F. Vit, T. Bittolo, A. Zucchetto, R. Papotti, E. Tissino, F. Pozzo, M. Degan, E. Zaina, I. Cattarossi, P. Nanni, R. Marasca, G. Reda, L. Laurenti, J. Olivieri, A. Chiarenza, L. Ballotta, A. Cuneo, M. Gentile, F. Morabito, A. Tafuri, F. Zaja, R. Foà, F. Di Raimondo, G. Del Poeta, V. Gattei

    Published 2022-06-01
    Get full text
    Article

Search Tools: